Evidence map›Paper›PMID 34956123›Full record

ArticleFrontiers in microbiology2021

Isolation and Characterization of Group III

Severin Michael Steffan, Golshan Shakeri, Jens Andre Hammerl, Corinna Kehrenberg, Elisa Peh, Manfred Rohde, Claudia Jackel, Madeleine Plotz, Sophie Kittler

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Antibiotics (Basel, Switzerland) · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Severin Michael SteffanInstitute for Food Quality and Food Safety, Foundation University of Veterinary Medicine Hannover, Hanover, Germany.
Golshan ShakeriDepartment of Food Hygiene and Aquaculture, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
Jens Andre HammerlDepartment Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Corinna KehrenbergInstitute for Veterinary Food Science, Justus-Liebig-University Giessen, Giessen, Germany.
Elisa PehInstitute for Food Quality and Food Safety, Foundation University of Veterinary Medicine Hannover, Hanover, Germany.
Manfred RohdeCentral Facility for Microscopy, Helmholtz Centre for Infection Research GmbH, Braunschweig, Germany.
Claudia JackelDepartment Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Madeleine PlotzInstitute for Food Quality and Food Safety, Foundation University of Veterinary Medicine Hannover, Hanover, Germany.
Sophie KittlerInstitute for Food Quality and Food Safety, Foundation University of Veterinary Medicine Hannover, Hanover, Germany.
University of Veterinary Medicine Hannover, Foundation · DEFederal Institute for Risk Assessment · DEFerdowsi University of Mashhad · IRHelmholtz Centre for Infection Research · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacteriophagesCampylobacter virusefficiency of plaquingnovel antimicrobialsone health approachphage biocontrolphage therapypoultry meat

Identifiers

PMID34956123
PMCPMC8696038
OpenAlexW4200602772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.